COLL vs PDD · P/E 17, rev $181.9M vs P/E 8.4, rev $61.75B
Collegium Pharmaceutical Inc (COLL) versus PDD Holdings Inc. (PDD) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Not investment advice. Open the COLL and PDD stock pages for the full models.
Not investment advice.